Copyright
©The Author(s) 2020.
World J Gastroenterol. Mar 28, 2020; 26(12): 1273-1285
Published online Mar 28, 2020. doi: 10.3748/wjg.v26.i12.1273
Published online Mar 28, 2020. doi: 10.3748/wjg.v26.i12.1273
Ref. | Etiology/Population | Genes and best 95%CI OR | Key points |
N (non-ACR/ACR) | |||
Yu et al[13] | Various | Recipient CD276: rs2127015 (0.05-0.93); NS for: rs11072431, rs11574495, rs12593558, rs12594627, rs3816661 rs7176654; Recipient TREML2: rs4714431, rs6915083, rs7754593, rs9394767 NS1 | Recipient's CD276 (rs2127015) T allele is weakly associated with ACR and with CD276 mRNA expression |
Eastern Asian | |||
334/54 | |||
Ostojic et al[14] | Alcoholic | Recipient CXCL9: rs10336 NS; Recipient CXCL10: rs3921 NS | No association found. CXCL9 (rs10336) is associated with earlier ACR occurrence and higher plasma CXCL9 concentrations |
European | |||
156/59 | |||
Sun et al[12] | Various | Recipient IL-17: rs2275913 (0.07-0.77)2 | Associated with increased IL-17 plasma concentration and with cyclosporine metabolism (CYP3A4 and CYP3A5 expression) |
Eastern Asian | |||
66/40 | |||
Verma et al[16] | Various | Recipient FOXP3: rs3761547, rs3761548, and rs2232365 NS | Association found only in a very small subgroup of steroid resistant ACR patients (N = 5) for rs3761548 |
Asian | |||
86/16 | |||
Associated with the degree of mixed lymphocyte reaction | |||
Thude et al[15] | Various | Recipient KLRB1: rs1135816 NS | No association found |
European | |||
163/178 | |||
Thude et al[8] | Various | Recipient HPA-3 a/b: rs5910 (1.749–41.8); Recipient/donor incompatibility: rs5910 (1.78–7.39); HPA-1, -2, -3, -5, -15 NS for all | HPA-3 incompatibility and HPA-3 b/b genotype were associated with higher incidence of ACR |
European | |||
53/43 | |||
There was no difference in the time of ACR occurrence | |||
Fereidooni et al[10] | Various | Recipient IL28B: rs12979860 NS | No association found |
Western Asian | |||
101/39 | |||
Valero-Hervás et al[11] | Various | Recipient C3 complement rs2230199 (0.09-0.77) | C3FF genotype is associated with lower incidence of ACR, independently after multivariate analysis for sex, HCV infection, therapy and donor type |
European | |||
277/185 |
- Citation: Kelava T, Turcic P, Markotic A, Ostojic A, Sisl D, Mrzljak A. Importance of genetic polymorphisms in liver transplantation outcomes. World J Gastroenterol 2020; 26(12): 1273-1285
- URL: https://www.wjgnet.com/1007-9327/full/v26/i12/1273.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i12.1273